Monte Rosa Therapeutics

Performance

About Monte Rosa Therapeutics

Monte Rosa Therapeutics is a biotechnology company focused on advancing cancer therapies through targeted protein degradation. The company develops degradation-based drug discovery platforms centered on molecular glue degrader chemistry, augmented by artificial intelligence, structural biology, and proteomics to promote ubiquitination and proteasomal degradation of disease-causing, undruggable proteins. Their science targets expand the frontier of medicine by enabling pharmacological protein knockout with high efficiency and precision. Monte Rosa operates internationally in the biopharma space, collaborating with researchers to translate cutting-edge biology into potential therapeutics.